caselaw.findlaw.com/pa-superior-court/1889831.html

JANSSEN PHARMACEUTICALS INC JOHNSON JOHNSON JANSSEN ... JANSSEN RESEARCH AND DEVELOPMENT, LLC NICHOLAS MURRAY, Appellant v. ... All of the cases in this mass tort action consist of male plaintiffs who allege they ...... 682, 42 U.S.C. § 201 et seq. and was approved or licensed; or is generally ...

caselaw.findlaw.com/pa-superior-court/1885246.html

JANSSEN PHARMACEUTICALS INC JOHNSON JOHNSON JANSSEN RESEARCH ... and Janssen Research & Development, LLC, have taken cross- appeals from the ... All of the cases in this mass tort involve male plaintiffs who allege they ...

www.law360.com/cases/59dd5989ac94675a6c000001

Janssen Pharmaceutical N.V. et al, case number 2:16-cv-06997, from California ... United States of America et al v. ... Janssen Research and Development, LLC ...

www.litigationandtrial.com/files/2016/06/Invokana-Janssen-Response.pdf

Oct 12, 2016 ... ... (S.D. Ill.), Allen v. Janssen Pharmaceuticals, Inc., et al., Case No. 3:15 ... id. at * 8–*11. In Brazil v. Janssen Research & Development LLC, No.

www.ncbi.nlm.nih.gov/pmc/articles/PMC5465257

Jun 9, 2017 ... ... with increases in anxiety symptoms in neuropsychiatric patients (Johnson et al. , 2010). ... were synthetized at Janssen Research & Development, LLC. .... To determine the selectivity ratio versus the OX2R, the affinity of the ...... Yeoh J. W., Campbell E. J., James M. H., Graham B. A., Dayas C. V. (2014).

www.janssen.com

Explore Janssen's innovative medical research and development practices, and see how Janssen is dedicated to the well-being of patients around the world.

www.jacionline.org/article/S0091-6749(14)00181-X/fulltext

Kim Campbell .... were generally maintained through week 24 in all guselkumab- treated patients. .... W., Murphy, E., Diveu, C., Wiekowski, M., Abbondanzo, S. et al. ... Guselkumab (CNTO 1959; Janssen Research & Development, LLC, Spring ..... expression of 1224 transcripts of nonlesional skin at baseline versus lesional  ...

ard.bmj.com/content/77/Suppl_2/134.1.full.pdf

Jun 14, 2018 ... tive to BL when compared to UST blockade (>90% vs~70%). In pts who ... [1] Langley RG, Tsai TF, Flavin S, Song M, Randazzo B, Wasfi Y, et al. Effi- ... Employee of: Janssen Research and Development, LLC, K. Campbell Share- ... research support from: Janssen Research and Development, LLC.

www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/arthritisadvisorycommittee/ucm569153.pdf

Jun 28, 2017 ... Janssen Research & Development, LLC. EDMS number: ...... Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the ...